Cargando…

Role of tau deposition in early cognitive decline in Down syndrome

INTRODUCTION: Drawing on the amyloid/tau/neurodegeneration (AT[N]) model, the study examined whether the tau positron emission tomography (PET) biomarker [(18)F]AV‐1451 was associated with episodic memory problems beyond what was predicted by the amyloid beta (Aβ) PET in Down syndrome (DS). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartley, Sigan L., Handen, Benjamin L., Tudorascu, Dana, Lee, Laise, Cohen, Annie, Piro‐Gambetti, Brianna, Zammit, Matthew, Klunk, William, Laymon, Charles, Zaman, Shahid, Ances, Beau M., Sabbagh, Marwan, Christian, Bradley T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976157/ https://www.ncbi.nlm.nih.gov/pubmed/35386473 http://dx.doi.org/10.1002/dad2.12256

Ejemplares similares

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Sleep and White Matter in Adults with Down Syndrome
por: Fleming, Victoria, et al.
Publicado: (2021)

White matter microstructure associations to amyloid burden in adults with Down syndrome
por: Bazydlo, Austin M., et al.
Publicado: (2021)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Untangling tau imaging
por: Villemagne, Victor L., et al.
Publicado: (2016)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau‐PET/MRI at 3T
por: Carlson, Mackenzie L., et al.
Publicado: (2021)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

White matter and its relationship with cognition in subjective cognitive decline
por: Ohlhauser, Lisa, et al.
Publicado: (2018)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
por: Collij, Lyduine E., et al.
Publicado: (2021)

CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
por: Pappas, Colleen, et al.
Publicado: (2020)

In vivo network models identify sex differences in the spread of tau pathology across the brain
por: Shokouhi, Sepideh, et al.
Publicado: (2020)

Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
por: Butler, Tracy, et al.
Publicado: (2022)

Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
por: Nimmo, Jacqui, et al.
Publicado: (2020)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rujs867tajog6i31o0cpmu55b8